Table 1 Clinical characteristics of the 106 patients with COVID-19 admitted to the RICU
From: Role of respiratory intermediate care units during the SARS-CoV-2 pandemic
Demographics | |
Age mean (SD) | 66 ± 12 |
Gender male (%) | 76 (72%) |
Mean body weight, kg mean (SD) | 83 ± 17 |
Body mass index, kg/m2 mean (SD) | 29 ± 6 |
Comorbidity | |
Systemic arterial hypertension | 57 (54%) |
Dyslipidemia | 30 (28%) |
Cardiovascular disease | 20 (19%) |
Chronic obstructive pulmonary Disease | 16(15%) |
Diabetes | 14 (13%) |
Chronic renal failure | 14 (13%) |
Obstructive sleep apnea | 10 (9%) |
Cerebrovascular disease | 7 (6.6%) |
Cancer history | 6 (6%) |
Organ transplantation | 5(5%) |
Asthma | 3(3%) |
Previous treatment | |
Statins | 19(18%) |
Angiotensin II receptor blockers | 9 (8.4%) |
Source of admission to RICU | |
Intensive care unit (step-down) | 65 (61%) |
COVID-19 ward (step-up) | 27 (26%) |
Emergency room (step-up) | 14 (13%) |